Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Kaposi Sarcoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT00064142
What this trial is testing

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
AIDS-related Kaposi SarcomaRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT00427414
What this trial is testing

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 14
Testing effectiveness (Phase 2)Study completedNCT00019188
What this trial is testing

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Epidemic Kaposi's SarcomaRecurrent Kaposi's Sarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00003720
What this trial is testing

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
Pfizer
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00295984
What this trial is testing

Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00051597
What this trial is testing

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

Who this might be right for
Hodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more
Seagen Inc. 70
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00020449
What this trial is testing

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00450320
What this trial is testing

Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 7
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Ended earlyNCT00006222
What this trial is testing

EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00019240
What this trial is testing

Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT00096538
What this trial is testing

Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 6
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Ended earlyNCT00686842
What this trial is testing

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Who this might be right for
Kaposi's Sarcoma
AIDS Malignancy Consortium 17
Testing effectiveness (Phase 2)Study completedNCT00024024
What this trial is testing

BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 59
Not applicableStudy completedNCT00075777
What this trial is testing

Valproic Acid in Treating Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Load More Results